Global burden, risk factor analysis, and prediction study of leukaemia from 1990 to 2030-Reference-Cited by-同舟云学术

Global burden, risk factor analysis, and prediction study of leukaemia from 1990 to 2030

Published:2024-08-23 Issue: Volume:14 Page:
ISSN:2047-2978
Container-title:Journal of Global Health
language:
Short-container-title:J Glob Health

Author:

Wang Wenjun¹,Zhang Donglei¹,Liang Qian²,Liu Xiaoyan¹,Shi Jun³,Zhou Fuling¹

Affiliation:

1. Department of Haematology, Zhongnan Hospital of Wuhan University, Wuhan, China

2. Zhoukou Central Hospital, Zhoukou, China

3. Regenerative Medicine Clinic, State Key Laboratory of Experimental Haematology, National Clinical Research Centre for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China

Publisher

International Society of Global Health

Reference54 articles.

1. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.;Fitzmaurice;JAMA Oncol,2017

2. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019.;GBD 2019 Adolescent Young Adult Cancer Collaborators;Lancet Oncol,2022

3. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.;Kocarnik;JAMA Oncol,2022

4. An update of current treatments for adult acute myeloid leukemia.;Dombret;Blood,2016

5. Which Tyrosine Kinase Inhibitors Should Be Selected as the First-Line Treatment for Chronic Myelogenous Leukemia in Chronic Phase?;Ono;Cancers (Basel),2021